TFF Pharmaceuticals, Inc.
- Raised $26 million (2020)
- 5 clinical trials
- Research grants: $864,948
- Founded 2018
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Arch Therapeutics, Inc.
- Raised $4.2 million (2022)
- 2 clinical trials
- FDA-cleared or approved devices
- Founded 2006
Co-Diagnostics, Inc.
Nasdaq: CODX
- Raised $47 million (2022)
- 1 FDA-registered device site
- Founded 2013
InkSpace Imaging, Inc.
- Raised $12 million (2023)
- FDA-cleared or approved devices
- Research grants: $3.8 million
Paragon 28, Inc.
- Raised $200,000 (2011)
- 8 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2011
Lifecore Biomedical
On BioBridgeX
- 1 FDA-registered device site
- 1 FDA-registered drug site
Minerva Surgical Inc
- Raised $15 million (2020)
- 6 clinical trials
- FDA-cleared or approved devices
March Biosciences, Inc.
- Raised $22 million (2024)
- 2 clinical trials, 2 active
- Research grants: $7.4 million
- Founded 2021
Avalo Therapeutics, Inc.
Nasdaq: AVTX
- Raised $131 million (2024)
- 10 clinical trials
- Founded 2011
Quince Therapeutics, Inc.
Nasdaq: QNCX
- Raised $115 million (2026)
- 10 clinical trials
- Founded 2012
Albireo Pharma, Inc.
- Raised $19 million (2012)
- 27 clinical trials
- Research grants: $1.2 million
Metritrack,Inc.
- Raised $325,000 (2018)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $411,058
ReAlta Life Sciences, Inc.
- Raised $25 million (2025)
- 6 clinical trials, 3 active
- Research grants: $3 million
- Founded 2018
RESTOR3D, Inc.
- Raised $85 million (2025)
- 24 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2017
LivaNova PLC
Nasdaq: LIVN
- 43 clinical trials, 2 active
- Founded 2015
Xenoport Inc
- Raised $20 million (2012)
- 27 clinical trials
- Research grants: $1.3 million
Altor Bioscience Corp
- Raised $30 million (2017)
- 15 clinical trials
- Research grants: $24 million
Lemaitre Vascular Inc
Nasdaq: LMAT
- 8 clinical trials, 5 active
- FDA-cleared or approved devices
Tenax Therapeutics, Inc.
Nasdaq: TENX
- Raised $100 million (2024)
- 9 clinical trials, 3 active
- Founded 2008
Verrica Pharmaceuticals Inc.
Nasdaq: VRCA
- Raised $50 million (2025)
- 9 clinical trials, 3 active
- Founded 2013
VivaQuant, LLC
- Private funding (2018)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $2.1 million
Icagen, Inc.
- Raised $7.3 million (2018)
- 5 clinical trials
- Research grants: $6.6 million
Akebia Therapeutics, Inc.
Nasdaq: AKBA
- Raised $14 million (2011)
- 37 clinical trials, 3 active
- Founded 2007
Talphera, Inc.
Nasdaq: TLPH
- Raised $17 million (2025)
- 18 clinical trials, 1 active
Vida Diagnostics Inc
- Raised $11 million (2023)
- FDA-cleared or approved devices
- Research grants: $3 million
- Founded 2005
ACTIV Surgical, Inc.
- Raised $15 million (2022)
- 5 clinical trials, 1 active
- Research grants: $485,538
- Founded 2014
Alessa Therapeutics, Inc.
- Raised $25 million (2025)
- 3 clinical trials, 2 active
- Research grants: $1.6 million
- Founded 2018
GRAIL, Inc.
Nasdaq: GRAL
- Raised $325 million (2025)
- 8 clinical trials, 5 active
- Founded 2015
Kura Oncology, Inc.
Nasdaq: KURA
- Raised $150 million (2024)
- 17 clinical trials, 6 active
NextCure, Inc.
Nasdaq: NXTC
- Raised $22 million (2025)
- 8 clinical trials, 2 active
- Founded 2015
Paradromics, Inc.
- Raised $50 million (2023)
- 1 clinical trial, 1 active
- Research grants: $7.9 million
- Founded 2015
Shape Medical Systems, Inc.
- Raised $8.3 million (2012)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $4.1 million
Spruce Biosciences, Inc.
Nasdaq: SPRB
- Raised $50 million (2025)
- 8 clinical trials, 1 active
- Founded 2016
Strand Therapeutics Inc.
- Raised $108 million (2026)
- 2 clinical trials, 2 active
- Research grants: $2 million
- Founded 2017
Veralox Therapeutics Inc.
- Raised $24 million (2023)
- 3 clinical trials
- Research grants: $1.2 million
- Founded 2018
Inflammatix, Inc.
- Raised $102 million (2021)
- 6 clinical trials, 1 active
- Research grants: $4.5 million
- Founded 2016
Protego Biopharma, Inc.
- Raised $33 million (2025)
- 1 clinical trial
- Research grants: $7.4 million
Vyriad, Inc.
- Raised $24 million (2019)
- 6 clinical trials, 3 active
- Research grants: $9.1 million
Carlsmed, Inc.
Nasdaq: CARL
- Raised $30 million (2022)
- FDA-cleared or approved devices
- Founded 2018
Atea Pharmaceuticals, Inc.
Nasdaq: AVIR
- Raised $107 million (2020)
- 36 clinical trials, 4 active
- Founded 2012
DBV Technologies S.A.
Nasdaq: DBVT
- Raised $307 million (2025)
- 16 clinical trials, 2 active
Endocyte Inc
- Raised $8.1 million (2010)
- 29 clinical trials, 1 active
- Research grants: $3.6 million
7 Hills Pharma Inc.
- Raised $1 million (2024)
- 2 clinical trials, 1 active
- Research grants: $28 million
Thermedical, Inc.
- Raised $11 million (2021)
- 3 clinical trials, 1 active
- Research grants: $16 million
Baxter Healthcare Corporation
- 138 clinical trials, 2 active
- FDA-cleared or approved devices
- 6 FDA-registered drug sites
Neumora Therapeutics, Inc.
Nasdaq: NMRA
- Raised $474 million (2023)
- 7 clinical trials
- Founded 2019
Pressure Biosciences Inc
- Raised $17 million (2019)
- Research grants: $3.1 million
Regulus Therapeutics Inc.
- Raised $35 million (2021)
- 3 clinical trials
- Research grants: $300,000
- Founded 2009
Sanofi
Nasdaq: SNY
- 1729 clinical trials, 172 active
- 7 FDA-registered drug sites
Steris Corp
- FDA-cleared or approved devices
- 8 FDA-registered drug sites
Published company profiles only; counts update daily. Data licences